Nivolumab in Patients With Type B3 Thymoma and Thymic Carcinoma (NIVOTHYM)
Clinical trial NCT03134118 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT03134118
- Sponsor
- European Organisation for Research and Treatment of Cancer - EORTC
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-04-11
- Primary completion
- 2023-09-05
- Enrollment
- 55
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.